Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | glycogen phosphorylase | 0.0114 | 0.5665 | 0.69 |
Mycobacterium ulcerans | glycogen phosphorylase GlgP | 0.0049 | 0.083 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0048 | 0.0756 | 0.0756 |
Giardia lamblia | Glycogen phosphorylase | 0.0114 | 0.5665 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0048 | 0.0756 | 0.0756 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0049 | 0.083 | 0.1466 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0114 | 0.5665 | 1 |
Echinococcus multilocularis | Glycosyl transferase, family 35 | 0.0114 | 0.5665 | 0.5665 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0171 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0048 | 0.0756 | 0.0756 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0171 | 1 | 1 |
Echinococcus granulosus | Glycosyl transferase family 35 | 0.0114 | 0.5665 | 0.5665 |
Schistosoma mansoni | alpha-glucosidase | 0.0147 | 0.821 | 1 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0171 | 1 | 1 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0171 | 1 | 1 |
Loa Loa (eye worm) | glycogen phosphorylase | 0.0114 | 0.5665 | 0.5665 |
Echinococcus multilocularis | glycogen phosphorylase | 0.0114 | 0.5665 | 0.5665 |
Chlamydia trachomatis | glycogen phosphorylase | 0.0114 | 0.5665 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0038 | 0 | 0.5 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0049 | 0.083 | 0.1466 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0048 | 0.0756 | 0.0921 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0038 | 0 | 0.5 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0114 | 0.5665 | 1 |
Schistosoma mansoni | glycogen phosphorylase | 0.0114 | 0.5665 | 0.69 |
Trypanosoma brucei | glucosidase, putative | 0.0038 | 0 | 0.5 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0038 | 0 | 0.5 |
Brugia malayi | carbohydrate phosphorylase | 0.0114 | 0.5665 | 0.5665 |
Echinococcus granulosus | glycogen phosphorylase | 0.0114 | 0.5665 | 0.5665 |
Entamoeba histolytica | glycogenphosphorylase, putative | 0.0049 | 0.083 | 0.1466 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0114 | 0.5665 | 1 |
Echinococcus multilocularis | glycogen phosphorylase | 0.0114 | 0.5665 | 0.5665 |
Onchocerca volvulus | Glycogen phosphorylase homolog | 0.0114 | 0.5665 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0048 | 0.0756 | 0.0756 |
Echinococcus granulosus | glycogen phosphorylase | 0.0114 | 0.5665 | 0.5665 |
Schistosoma mansoni | glycogen phosphorylase | 0.0049 | 0.083 | 0.1011 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0048 | 0.0756 | 0.0756 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0048 | 0.0756 | 0.0756 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0048 | 0.0756 | 0.0921 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0114 | 0.5665 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0048 | 0.0756 | 0.0921 |
Schistosoma mansoni | alpha-glucosidase | 0.0147 | 0.821 | 1 |
Mycobacterium tuberculosis | Probable glycogen phosphorylase GlgP | 0.0049 | 0.083 | 0.5 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0038 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Glyceamia evolution (functional) | = -13 % | Evolution of glycemia 2 hr after first administration at the dose of 200 mg/kg in rat | ChEMBL. | 12127514 |
Glyceamia evolution (functional) | = -7 % | Evolution of glycemia 2 hr after the last administration for 4 days chronic treatment at the dose of 20 mg/kg in rat | ChEMBL. | 12127514 |
Glyceamia evolution (functional) | = -3 % | Evolution of glycemia 2 hr after first administration at the dose of 20 mg/kg in rat | ChEMBL. | 12127514 |
Glyceamia evolution (functional) | = -3 % | Evolution of glycemia 2 hr after the last administration for 4 days chronic treatment at the dose of 200 mg/kg in rat | ChEMBL. | 12127514 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.